Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management

BACKGROUND: There is conflicting evidence of benefit versus harm for warfarin anticoagulation in hemodialysis patients with atrial fibrillation. This equipoise may be explained by suboptimal Time in Therapeutic Range (TTR), which correlates well with thromboembolic and bleeding complications. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahbahani, Hamad, AlTurki, Ahmed, Dawas, Ahmed, Lipman, Mark L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759837/
https://www.ncbi.nlm.nih.gov/pubmed/29310600
http://dx.doi.org/10.1186/s12882-017-0809-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759837/
https://www.ncbi.nlm.nih.gov/pubmed/29310600
http://dx.doi.org/10.1186/s12882-017-0809-x

Ejemplares similares